美国 Celgene 新基医药 
Celgene的公司成立于1980年，其总部在美国新泽西洲Summit，现拥有2441名员工，从事治疗癌症和免疫炎症等疾病以及研究、开发、推广、销售相关药品和创新疗法。它是一家全球性的生物制药公司。
VIDAZA：VIDAZA用于治疗骨髓增生异常综合症亚型；难治性贫血（ RA ）或难治性贫血伴环状铁（ RARS ），难治性贫血伴过剩（难治性贫血） ，难治性贫血伴过剩转变（难治性贫血） ，慢性粒细胞白血病（ CMMoL ）。

THALOMID(thalidomide)医药：THALOMID(thalidomide)医药配合塞米松用于治疗新诊断的多发性骨髓瘤。

REVLIMID? (lenalidomide)医药：REVLIMID? (lenalidomide)医药配合塞米松，用于治疗患者的多发性骨髓瘤和输血依赖性贫血。

Committed to Improving the Lives of Patients Worldwide
Celgene is a multinational biopharmaceutical company committed to improving the lives of patients worldwide.

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

There are numerous clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin's lymphoma (NHL), glioblastoma, and ovarian, pancreatic and prostate cancer.

As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.

Our History
Explore Celgene's history - from our modest beginnings to our current position as a globally integrated and culturally diverse biopharmaceutical company.

Our People
Celgene employs more than 2,600 employees worldwide. Learn about the values that define our people.

World Map
Our commitment to patients extends around the world. Find a comprehensive listing of domestic and international Celgene offices.

Intellectual Property
Discover Celgene's deep and diverse intellectual property portfolio - a variety of novel scientific targets and approaches.

California Declaration of Compliance